Cargando…

Oral administration of a dual ET(A)/ET(B) receptor antagonist promotes neuroprotection in a rodent model of glaucoma

PURPOSE: Glaucoma is a neurodegenerative disease associated with elevated intraocular pressure and characterized by optic nerve axonal degeneration, cupping of the optic disc, and loss of retinal ganglion cells (RGCs). The endothelin (ET) system of vasoactive peptides (ET-1, ET-2, ET-3) and their G-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kodati, Bindu, McGrady, Nolan R., Jefferies, Hayden B., Stankowska, Dorota L., Krishnamoorthy, Raghu R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491150/ https://www.ncbi.nlm.nih.gov/pubmed/36274816

Ejemplares similares

Upregulation of the endothelin A (ET(A)) receptor and its association with neurodegeneration in a rodent model of glaucoma
por: McGrady, Nolan R., et al.
Publicado: (2017)

Involvement of c-Jun N-terminal kinase 2 (JNK2) in Endothelin-1 (ET-1) Mediated Neurodegeneration of Retinal Ganglion Cells
por: Kodati, Bindu, et al.
Publicado: (2021)

Involvement of AP-1 and C/EBPβ in Upregulation of Endothelin B (ET(B)) Receptor Expression in a Rodent Model of Glaucoma
por: He, Shaoqing, et al.
Publicado: (2013)

Role of mitophagy in ocular neurodegeneration
por: Brooks, Calvin D., et al.
Publicado: (2023)

Bcl-2, Bcl-xL, and p-AKT are involved in neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma
por: Phatak, Nitasha R., et al.
Publicado: (2016)

Nanoencapsulated hybrid compound SA-2 with long-lasting intraocular pressure–lowering activity in rodent eyes
por: Stankowska, Dorota L., et al.
Publicado: (2021)

Endothelin-1 Mediated Decrease in Mitochondrial Gene Expression and Bioenergetics Contribute to Neurodegeneration of Retinal Ganglion Cells
por: Chaphalkar, Renuka M., et al.
Publicado: (2020)

Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)

Correction: Systemically administered peptain-1 inhibits retinal ganglion cell death in animal models: implications for neuroprotection in glaucoma
por: Stankowska, Dorota L., et al.
Publicado: (2019)

Neuroprotection by Wld(S) depends on retinal ganglion cell type and age in glaucoma
por: Risner, Michael L., et al.
Publicado: (2021)

Restoring the Extracellular Matrix: A Neuroprotective Role for Collagen Mimetic Peptides in Experimental Glaucoma
por: McGrady, Nolan R., et al.
Publicado: (2021)

Neuroprotective Effects of Transferrin in Experimental Glaucoma Models
por: Youale, Jenny, et al.
Publicado: (2022)

Modulating mitochondrial calcium channels (TRPM2/MCU/NCX) as a therapeutic strategy for neurodegenerative disorders
por: Johnson, Gretchen A., et al.
Publicado: (2023)

Neuroprotection of Rodent and Human Retinal Ganglion Cells In Vitro/Ex Vivo by the Hybrid Small Molecule SA-2
por: Pham, Jennifer H., et al.
Publicado: (2022)

Role of Glucocorticoids and Glucocorticoid Receptors in Glaucoma Pathogenesis
por: Patel, Pinkal D., et al.
Publicado: (2023)

Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
por: Nam, Mi-Hyun, et al.
Publicado: (2022)

TRPV1 Tunes Optic Nerve Axon Excitability in Glaucoma
por: McGrady, Nolan R., et al.
Publicado: (2020)

Endothelin B Receptors Contribute to Retinal Ganglion Cell Loss in a Rat Model of Glaucoma
por: Minton, Alena Z., et al.
Publicado: (2012)

Bax Contributes to Retinal Ganglion Cell Dendritic Degeneration During Glaucoma
por: Risner, Michael L., et al.
Publicado: (2022)

Retinal ganglion cells adapt to ionic stress in experimental glaucoma
por: Boal, Andrew M., et al.
Publicado: (2023)

Early-Onset Glaucoma in egl1 Mice Homozygous for Pitx2 Mutation
por: Kodati, Bindu, et al.
Publicado: (2022)

Neuroprotection in glaucoma
por: Vishwaraj, C R, et al.
Publicado: (2022)

New perspectives of immunomodulation and neuroprotection in glaucoma
por: Skopiński, Piotr, et al.
Publicado: (2021)

Neuroprotection in glaucoma
por: Vasudevan, Sushil K, et al.
Publicado: (2011)

Neuroprotection in Glaucoma
por: Nilforushan, Naveed
Publicado: (2012)

Neuroprotection in Glaucoma
por: Doozandeh, Azadeh, et al.
Publicado: (2016)

Mesenchymal Stem Cell–Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma
por: Mead, Ben, et al.
Publicado: (2018)

Longer Rodent Bioassay: Huff et al. Respond
por: Huff, James, et al.
Publicado: (2008)

Astragaloside IV Attenuates Ocular Hypertension in a Mouse Model of TGFβ2 Induced Primary Open Angle Glaucoma
por: Kasetti, Ramesh B., et al.
Publicado: (2021)

Hypothermia plus Erythropoietin for neonatal neuroprotection? Commentary on Fan et al. and Fang et al.
por: Juul, Sandra E.
Publicado: (2013)

Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.
por: Raghu, Ganesh, et al.
Publicado: (2022)

Neuroprotective agents in the management of glaucoma
por: Nucci, C., et al.
Publicado: (2018)

Neurodegeneration and Neuroprotection in Glaucoma
por: Gauthier, Angela C., et al.
Publicado: (2016)

Neuroprotective therapies for glaucoma
por: Song, Wei, et al.
Publicado: (2015)

Neuroprotection in glaucoma-electrophysiology
por: Lešták, Ján, et al.
Publicado: (2020)

The Rodent Uterotrophic Assay: Response to Ashby and Newbold et al.
por: Markey, CM
Publicado: (2001)

Selective improvement of pulmonary arterial hypertension with a dual ET(A)/ET(B) receptors antagonist in the apolipoprotein E(−/−) model of PAH and atherosclerosis
por: Renshall, Lewis, et al.
Publicado: (2017)

Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ET(A) Versus ET(B) Receptors and on the Functionality of Endothelial ET(B) Receptors
por: Iglarz, Marc, et al.
Publicado: (2015)

Analyse et conception orientées objets
por: Booch, Grady
Publicado: (1994)

Current perspective of neuroprotection and glaucoma
por: Tian, Kailin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rcvt7193kgk3qk1r2te80qjvp4